Exagen (XGN) Change in Accured Expenses (2018 - 2026)

Exagen has reported Change in Accured Expenses for 9 years, with the latest figure at -$1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 9.8% year-over-year to -$1.6 million; the trailing twelve-month figure through Mar 2026 stood at $112000.0 (up 193.33% YoY), and the FY2025 full-year result was $251000.0, up 288.72% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$1.6 million, down from $681000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $1.2 million in Q3 2023, with the low at -$1.6 million in Q1 2026.
• Historically, Change in Accured Expenses has averaged -$20235.3 across 5 years, with a median of $89000.0 in 2022.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses tumbled 645.45% — and 2023, when it jumped 903.37%.
• Exagen's Change in Accured Expenses stood at -$1.3 million in 2022, then surged by 138.8% to $497000.0 in 2023, then surged by 102.62% to $1.0 million in 2024, then sank by 32.37% to $681000.0 in 2025, then plunged by 328.63% to -$1.6 million in 2026.
• The last three Change in Accured Expenses figures came in at -$1.6 million (Q1 2026), $681000.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.